Performance
Trailing returns
| 1 day | +0.74% |
| |||
| 1 week |
| -0.58% | |||
| 4 week |
| -1.53% | |||
| 3 month | +3.06% |
| |||
| YTD | +12.75% |
| |||
| 1 year | +32.67% |
| |||
| 3 years* | - | ||||
| 5 years* | - | ||||
| *annualized | |||||
| Best 3 month return | +12.69% | |
| Worst 3 month return | -13.86% |
Morningstar statistics
Morningstar category: UK Equity Income
Morningstar style Learn more
| Large | |||
| Mid | |||
| Small | |||
| Value | Blend | Growth |
Key statistics
| Total assets | 879.52M | |
| Front load | 0.00% | |
| Deferred load | - | |
| Expense ratio | - | |
| Management fee | 0.75% | |
| Fund family | Schroder Unit Trusts (UK) |
Asset allocation
| Cash | 3.20% | |
| Stocks | 98.21% | |
| Bonds | 0.00% | |
| Other | -1.41% |
Purchase information
| Initial | �3,000,000 | |
| Additional | �100,000 |
0.000.00(0.00%)
Jun 17, 4:00PM GMT+1
Description
The fund�s objective is to provide income with potential for capital growth primarily through investment in equity and equity-related securities of UK companies. The fund will also use derivative instruments to generate additional income. The Manager may selectively sell short dated call options over securities or portfolios of securities held by the Fund or indices, in order to generate additional income by setting target 'strike' prices at which those securities may be sold in the future. The Manager is also permitted to sell put options on securities or portfolios of securities which are not held by the Fund, or indices, at target prices that are pre-set below the current market level. The Manager may also, for the purpose of efficient management, use derivative instruments which replicate the performance of a basket of short dated call options or a combination of equity securities and short dated call options.
Asset manager:
Thomas See (Started: Apr 30, 2009)
Thomas See (Started: Apr 30, 2009)
Advisor Company:
Schroder Unit Trusts Limited
Schroder Unit Trusts Limited
Risk
| 1 year | 3 years | 5 years | 10 years | ||
| Alpha* | 11.85 | - | - | - | |
| Beta* | 0.70 | - | - | - | |
| Mean annual return | 1.92 | - | - | - | |
| R-squared* | 60.33 | - | - | - | |
| Standard deviation | 10.30 | - | - | - | |
| Sharpe ratio | 2.17 | - | - | - | |
| * Against standard index | |||||
Top 10 holdings
| Security | Net Assets | |
| AstraZeneca PLC (AZN) | 6.20% | |
| Vodafone Group PLC (VODPF) | 5.46% | |
| GlaxoSmithKline PLC (GLAXF) | 5.17% | |
| BP PLC (BPAQF) | 5.04% | |
| Lloyds Banking Group PLC (LLOY) | 4.96% | |
| Barclays PLC (BCLYF) | 4.81% | |
| Legal & General Group PLC (LGEN) | 3.92% | |
| Rentokil Initial PLC (RKLIF) | 3.83% | |
| Royal Dutch Shell PLC Class B (RDSB) | 3.71% | |
| Merck & Co Inc (MRK) | 3.68% |